quinoxalines has been researched along with cardiovascular agents in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HITZENBERGER, G; HORNYKIEWICZ, O; ZELLNER, H | 1 |
| Anderson, TJ; Ellis, A; Pannirselvam, M; Triggle, CR | 1 |
| Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X | 1 |
| Chawla, PS; Kochar, MS | 1 |
| Abbate, A; Mezzaroma, E; Seropian, IM; Toldo, S; Van Tassell, BW | 1 |
| Karakossian, MH; Maiz, J; Otis, TS; Pakaprot, N; Robleto, K; Thompson, RF | 1 |
1 review(s) available for quinoxalines and cardiovascular agents
| Article | Year |
|---|---|
What's new in clinical pharmacology and therapeutics.
Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines | 2008 |
5 other study(ies) available for quinoxalines and cardiovascular agents
| Article | Year |
|---|---|
[Experimental-pharmacological and clinical studies on a new spasmolytic "Spadon" (test name P 201-1)].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Biomedical Research; Cardiovascular Agents; Muscle Relaxants, Central; Parasympatholytics; Quinoxalines | 1963 |
Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Apamin; Cardiovascular Agents; Catalase; Charybdotoxin; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Hydrogen Peroxide; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Potassium Channel Blockers; Potassium Chloride; Quinoxalines; Tetraethylammonium; Vasodilator Agents | 2003 |
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Effects of PI3Kgamma inhibition using AS-605240 in acute myocardial infarction.
Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Genotype; Mice; Mice, Knockout; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phenotype; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinoxalines; Thiazolidinediones; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Prolonging the postcomplex spike pause speeds eyeblink conditioning.
Topics: Analysis of Variance; Animals; Benzimidazoles; Blinking; Calcium Channel Agonists; Cardiovascular Agents; Cerebellar Nuclei; Cerebellum; Conditioning, Eyelid; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Learning; Mice; Nerve Fibers; Picrotoxin; Purkinje Cells; Pyrimidines; Quinoxalines; Rats; Rats, Sprague-Dawley; Time Factors | 2012 |